During the last session, Advaxis, Inc. (NASDAQ:ADXS)’s traded shares were 2,173,149, with the beta value of the company hitting 2.56. At the end of the trading day, the stock’s price was $0.7, reflecting an intraday loss of -5.56% or -$0.04. The 52-week high for the ADXS share is $1.57, that puts it down -124.29% from that peak though still a striking +62.29% gain since the share price plummeted to a 52-week low of $0.264. The company’s market capitalization is $84.01 Million, and the average intraday trading volume over the past 10 days was 2.22 Million shares, and the average trade volume was 12.71 Million shares over the past three months.
Advaxis, Inc. (ADXS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2. ADXS has a Sell rating from none of the analyst(s) out of 1 analysts who have looked at this stock. Neither of the analyst(s) recommend to Hold the stock while none of them suggest Overweight, and 1 recommend a Buy rating for it. None of the analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $0.
Advaxis, Inc. (NASDAQ:ADXS): Trading Information
Advaxis, Inc. (ADXS) registered a -5.56% downside in the last session and has traded in the red over the past 5 sessions. The stock spiked 11.82% in intraday trading to $0.797 this Thursday, Apr 01, hitting a weekly high. The stock’s 5-day price performance is -3.11%, and it has moved by 3.4% in 30 days. Based on these gigs, the overall price performance for the year is 101.66%. The short interest in Advaxis, Inc. (NASDAQ:ADXS) is 5.28 Million shares and it means that shorts have 0.42 day(s) to cover.
The consensus price target of analysts on Wall Street is $5, which implies an increase of 614.29% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5 and $5 respectively. As a result, ADXS is trading at a discount of 614.29% off the target high and 614.29% off the low.
Advaxis, Inc. (ADXS) projections and forecasts
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 55.6%. While earnings are projected to return 60.3% in 2021, the next five years will return 0% per annum.
Advaxis, Inc. (NASDAQ:ADXS)’s Biggest Investors
Advaxis, Inc. insiders own 0.07% of total outstanding shares while institutional holders control 14.68%, with the float percentage being 14.69%. Renaissance Technologies, LLC is the largest shareholder of the company, while 43 institutions own stock in it. As of Dec 30, 2020, the company held over 6.07 Million shares (or 5.04% of all shares), a total value of $2.12 Million in shares.
The next largest institutional holding, with 870.01 Thousand shares, is of Blackrock Inc.’s that is approximately 0.72% of outstanding shares. At the market price on Dec 30, 2020, these shares were valued at $303.37 Thousand.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Also, the Mutual Funds coming in first place with the largest holdings of Advaxis, Inc. (ADXS) shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. Data provided on Dec 30, 2020 indicates that Vanguard Extended Market Index Fund owns about 811,182 shares. This amounts to just over 0.67 percent of the company’s overall shares, with a $282.86 Thousand market value. The same data shows that the other fund manager holds slightly less at 431.94 Thousand, or about 0.36% of the stock, which is worth about $362.78 Thousand.